Home ETF List About

Portfolio Holdings Detail for ISIN IE00B8FHGS14
Stock Name / FundiShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMINV(GBX) LSE
ETF TickerIQQ0(EUR) F
ETF TickerMINV.LS(GBX) CXE
ETF TickerMVOL.LS(USD) CXE
ETF TickerMVOL.MI(EUR) CXE
ETF TickerMVOLz(CHF) CXE
ETF TickerMVOL(EUR) ETF Plus
ETF TickerMINV.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-11-12 (Wednesday)11,809USD 8,050,431REGN holding increased by 84670USD 8,050,4310USD 84,670 USD 681.72 USD 674.55
2025-11-11 (Tuesday)11,809USD 7,965,761REGN holding increased by 233936USD 7,965,7610USD 233,936 USD 674.55 USD 654.74
2025-11-10 (Monday)11,809USD 7,731,825REGN holding decreased by -32947USD 7,731,8250USD -32,947 USD 654.74 USD 657.53
2025-11-07 (Friday)11,809USD 7,764,772REGN holding increased by 125884USD 7,764,7720USD 125,884 USD 657.53 USD 646.87
2025-11-06 (Thursday)11,809USD 7,638,888REGN holding increased by 31648USD 7,638,8880USD 31,648 USD 646.87 USD 644.19
2025-11-05 (Wednesday)11,809USD 7,607,240REGN holding increased by 191188USD 7,607,2400USD 191,188 USD 644.19 USD 628
2025-11-04 (Tuesday)11,809REGN holding decreased by -112USD 7,416,052REGN holding decreased by -240210USD 7,416,052-112USD -240,210 USD 628 USD 642.25
2025-11-03 (Monday)11,921USD 7,656,262REGN holding decreased by -113846USD 7,656,2620USD -113,846 USD 642.25 USD 651.8
2025-10-31 (Friday)11,921REGN holding increased by 53USD 7,770,108REGN holding increased by 7961USD 7,770,10853USD 7,961 USD 651.8 USD 654.04
2025-10-30 (Thursday)11,868USD 7,762,147REGN holding increased by 13411USD 7,762,1470USD 13,411 USD 654.04 USD 652.91
2025-10-29 (Wednesday)11,868USD 7,748,736REGN holding decreased by -18633USD 7,748,7360USD -18,633 USD 652.91 USD 654.48
2025-10-28 (Tuesday)11,868REGN holding decreased by -108USD 7,767,369REGN holding increased by 757696USD 7,767,369-108USD 757,696 USD 654.48 USD 585.31
2025-10-27 (Monday)11,976USD 7,009,673REGN holding increased by 88144USD 7,009,6730USD 88,144 USD 585.31 USD 577.95
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00B8FHGS14

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-04SELL-112646.221625.140 627.248USD -70,252 637.26 Profit of 1,122 on sale
2025-10-31BUY53659.760645.000 646.476USD 34,263 637.17
2025-10-28SELL-108654.480655.700 655.578USD -70,802 636.91 Loss of -2,016 on sale
2025-10-21SELL-106579.340582.410 582.103USD -61,703 638.39 Profit of 5,967 on sale
2025-10-14SELL-53572.600576.180 575.822USD -30,519 640.11 Profit of 3,408 on sale
2025-10-02SELL-217600.000605.410 604.869USD -131,257 640.55 Profit of 7,743 on sale
2025-09-25SELL-53555.510579.000 576.651USD -30,563 642.58 Profit of 3,494 on sale
2025-09-24SELL-232576.980577.980 577.880USD -134,068 642.95 Profit of 15,096 on sale
2025-09-16BUY48575.060579.400 578.966USD 27,790 643.92
2025-09-12SELL-212560.000570.000 569.000USD -120,628 644.83 Profit of 16,075 on sale
2025-07-23SELL-251572.390576.700 576.269USD -144,644 651.60 Profit of 18,908 on sale
2025-07-22SELL-328560.930563.000 562.793USD -184,596 652.18 Profit of 29,317 on sale
2025-07-21SELL-164545.530552.980 552.235USD -90,567 652.86 Profit of 16,502 on sale
2025-07-15SELL-328547.960574.750 572.071USD -187,639 655.64 Profit of 27,411 on sale
2025-07-11SELL-164567.740568.460 568.388USD -93,216 656.80 Profit of 14,499 on sale
2025-07-02BUY82547.740551.500 551.124USD 45,192 662.09
2025-06-30SELL-246525.000526.080 525.972USD -129,389 663.05 Profit of 33,722 on sale
2025-06-27SELL-264521.000531.210 530.189USD -139,970 664.06 Profit of 35,342 on sale
2025-06-26BUY82521.000524.520 524.168USD 42,982 665.08
2025-06-25SELL-82520.290525.630 525.096USD -43,058 666.12 Profit of 11,564 on sale
2025-06-16SELL-832522.680538.200 536.648USD -446,491 671.72 Profit of 112,379 on sale
2025-06-13SELL-82529.240529.550 529.519USD -43,421 672.79 Profit of 11,748 on sale
2025-06-12SELL-164521.840525.220 524.882USD -86,081 673.93 Profit of 24,445 on sale
2025-06-11SELL-410518.600528.370 527.393USD -216,231 675.12 Profit of 60,568 on sale
2025-06-09SELL-82517.600518.270 518.203USD -42,493 677.52 Profit of 13,064 on sale
2025-05-30SELL-81490.280519.780 516.830USD -41,863 686.74 Profit of 13,763 on sale
2025-05-28SELL-81591.850606.000 604.585USD -48,971 688.20 Profit of 6,773 on sale
2025-05-21SELL-81604.620617.520 616.230USD -49,915 692.16 Profit of 6,150 on sale
2025-05-14SELL-1,105571.360580.560 579.640USD -640,502 696.66 Profit of 129,302 on sale
2025-05-09BUY421527.780552.840 550.334USD 231,691 700.47
2025-05-07SELL-324560.930568.130 567.410USD -183,841 703.23 Profit of 44,006 on sale
2025-05-01BUY81590.000593.930 593.537USD 48,076 707.69
2025-04-29SELL-902568.910579.980 578.873USD -522,143 710.17 Profit of 118,432 on sale
2025-04-28SELL-82610.860614.830 614.433USD -50,384 711.18 Profit of 7,933 on sale
2025-04-25BUY82602.640602.790 602.775USD 49,428 712.28
2025-04-23BUY847587.850603.770 602.178USD 510,045 714.75
2025-04-22BUY720585.490587.100 586.939USD 422,596 716.11
2025-04-15SELL-240557.910575.200 573.471USD -137,633 723.04 Profit of 35,898 on sale
2025-04-14BUY416571.060574.720 574.354USD 238,931 724.73
2025-04-11BUY406554.180555.530 555.395USD 225,490 726.65
2025-04-09SELL-240576.720580.730 580.329USD -139,279 730.45 Profit of 36,028 on sale
2025-04-08SELL-320556.810586.030 583.108USD -186,595 732.46 Profit of 47,794 on sale
2025-04-07SELL-80572.780591.540 589.664USD -47,173 734.34 Profit of 11,574 on sale
2025-04-04BUY80573.450612.990 609.036USD 48,723 736.26
2025-04-01BUY320617.000641.240 638.816USD 204,421 739.06
2025-03-27SELL-160635.830643.430 642.670USD -102,827 742.98 Profit of 16,050 on sale
2025-03-21SELL-80658.480661.000 660.748USD -52,860 748.03 Profit of 6,982 on sale
2025-03-14BUY240666.870686.980 684.969USD 164,393 753.67
2025-03-13BUY80680.610698.950 697.116USD 55,769 754.73
2025-03-12BUY160689.500712.460 710.164USD 113,626 755.68
2025-03-11BUY160718.160747.700 744.746USD 119,159 756.24
2025-03-10SELL-80744.830748.290 747.944USD -59,836 756.42 Profit of 678 on sale
2025-03-07BUY1,343707.510729.750 727.526USD 977,067 757.17
2025-03-05BUY400687.150692.790 692.226USD 276,890 758.26
2025-03-04BUY160675.490697.460 695.263USD 111,242 759.58
2025-03-03BUY320684.870704.640 702.663USD 224,852 760.78
2025-02-27BUY80702.780721.000 719.178USD 57,534 762.78
2025-02-26BUY640706.940721.410 719.963USD 460,776 763.73
2025-02-25BUY160723.470739.000 737.447USD 117,992 764.42
2025-02-20BUY240696.020703.140 702.428USD 168,583 767.76
2025-02-05BUY80716.720729.250 727.997USD 58,240 787.99
2025-02-04BUY80697.050709.980 708.687USD 56,695 790.10
2025-01-31SELL-80672.980688.000 686.498USD -54,920 795.96 Profit of 8,757 on sale
2025-01-30BUY80683.080689.620 688.966USD 55,117 798.79
2025-01-29SELL-80687.270697.570 696.540USD -55,723 801.65 Profit of 8,408 on sale
2025-01-28BUY160686.330690.300 689.903USD 110,384 804.68
2025-01-27SELL-80684.710698.450 697.076USD -55,766 807.92 Profit of 8,868 on sale
2024-12-10SELL-80778.500791.490 790.191USD -63,215 820.13 Profit of 2,395 on sale
2024-12-03SELL-160749.570770.000 767.957USD -122,873 829.52 Profit of 9,850 on sale
2024-11-29SELL-80750.220754.510 754.081USD -60,326 835.15 Profit of 6,486 on sale
2024-11-25SELL-502749.510757.860 757.025USD -380,027 850.07 Profit of 46,711 on sale
2024-11-22SELL-246738.000751.400 750.060USD -184,515 855.41 Profit of 25,916 on sale
2024-11-05SELL-656829.430836.630 835.910USD -548,357 911.23 Profit of 49,409 on sale
2024-10-29BUY82927.330932.380 931.875USD 76,414 943.79
2024-10-24BUY82928.900952.020 949.708USD 77,876 957.41
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.